The X11 proteins, Aβ production and Alzheimer's disease

Trends in Neurosciences

Volumn 29, Issue 5, 2006, Pages 280-285

  Miller, Christopher C J ^a   McLoughlin, Declan M ^a   Lau, Kwok Fai ^a   Tennant, Maria E ^a   Rogelj, Boris ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; AMYLOID PRECURSOR PROTEIN; COPPER PROTEIN; PRESENILIN 1; APBA1 PROTEIN, HUMAN; APBA1 PROTEIN, MOUSE; APBA2 PROTEIN, MOUSE; ASPARTIC PROTEINASE; BACE1 PROTEIN, HUMAN; BACE1 PROTEIN, MOUSE; CADHERIN; CARRIER PROTEIN; COPPER; NERVE PROTEIN; PROTEINASE; SECRETASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ALZHEIMER DISEASE; BINDING AFFINITY; COPPER METABOLISM; DRUG TARGETING; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; AMINO ACID SEQUENCE; ANIMAL; DOWN REGULATION; METABOLISM; MOLECULAR GENETICS; MOUSE; NERVE CELL; PHYSIOLOGY; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ENDOPEPTIDASES; CADHERINS; CARRIER PROTEINS; COPPER; DOWN-REGULATION; ENDOPEPTIDASES; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; NEURONS; PROTEIN INTERACTION MAPPING; SIGNAL TRANSDUCTION;

EID: 33646584550     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2006.03.001     Document Type: Review

References (70)

1. Wilquet V., and De Strooper B. Amyloid-β precursor protein processing in neurodegeneration. Curr. Opin. Neurobiol. 14 (2004) 582-588
2. King G.D., and Turner R.S. Adaptor protein interactions: modulators of amyloid precursor protein metabolism and Alzheimer's disease risk?. Exp. Neurol. 185 (2004) 208-219
3. McLoughlin D.M., and Miller C.C.J. The intracellular cytoplasmic domain of the Alzheimer's disease amyloid precursor protein interacts with phosphotyrosine binding domain proteins in the yeast two-hybrid system. FEBS Lett. 397 (1996) 197-200
4. Bressler S.L., et al. cDNA cloning and chromosome mapping of the human Fe65 gene: interaction of the conserved cytoplasmic domains of the human β-amyloid precursor protein and its homologues with the mouse Fe65 protein. Hum. Mol. Genet. 5 (1996) 1589-1598
5. Fiore F., et al. The regions of the Fe65 protein homologous to the phosphotyrosine interaction phosphotyrosine binding domain of Shc bind the intracellular domain of the Alzheimer's amyloid precursor protein. J. Biol. Chem. 270 (1995) 30853-30856
6. Borg J.-P., et al. The phosphotyrosine interaction domains of X11 and Fe65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol. Cell. Biol. 16 (1996) 6229-6241
7. Guénette S.Y., et al. Association of a novel human FE65-like protein with the cytoplasmic domain of the β-amyloid precursor protein. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 10832-10837
8. Tomita S., et al. Interaction of a neuron-specific protein containing PDZ domains with Alzheimer's amyloid precursor protein. J. Biol. Chem. 274 (1999) 2243-2254
9. Cao X., and Südhof T.C. A transcriptively active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293 (2001) 115-120
10. Louvi A., and Artavanis-Tsakonas S. Notch signalling in vertebrate neural development. Nat. Rev. Neurosci. 7 (2006) 93-102
11. Cao X., and Sudhof T.C. Dissection of APP-dependent transcriptional transactivation. J. Biol. Chem. 279 (2004) 24601-24611
12. Hass M.R., and Yankner B.A. A γ-secretase independent mechanism of signal transduction by the amyloid precursor protein. J. Biol. Chem. 280 (2005) 36895-36904
13. Baek S.H., et al. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-κB and β-amyloid precursor protein. Cell 110 (2002) 55-67
14. Telese F., et al. Transcription regulation by the adaptor protein Fe65 and the nucleosome assembly factor SET. EMBO Rep. 6 (2005) 77-82
15. Bimonte M., et al. Mutation of the feh-1 gene, the Caenorhabditis elegans orthologue of mammalian Fe65, decreases the expression of two acetylcholinesterase genes. Eur. J. Neurosci. 20 (2004) 1483-1488
16. Kim H.S., et al. C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3β expression. FASEB J. 17 (2003) 1951-1953
17. Von Rotz R.C., et al. The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor. J. Cell Sci. 117 (2004) 4435-4448
18. Pardossi-Piquard R., et al. Presenilin-dependent transcriptional control of the Aβ-degrading enzyme neprilysin by intracellular domains of βAPP and APLP. Neuron 46 (2005) 541-554
19. Biederer T., et al. Regulation of APP-dependent transcription complexes by Mint/X11s: differential functions of Mint isoforms. J. Neurosci. 22 (2002) 7340-7351
20. Lau K.-F., et al. Fe65 and X11β co-localize with and compete for binding to the amyloid precursor protein. NeuroReport 11 (2000) 3607-3610
21. Butz S., et al. A tripartite protein complex with the potential to couple synaptic vesicle exocytosis to cell adhesion in the brain. Cell 94 (1998) 773-782
22. Setou M., et al. Kinesin superfamily motor protein KIF17 and mLin-10 in NMDA receptor-containing vesicle transport. Science 288 (2000) 1796-1802
23. McLoughlin D.M., et al. The neuronal adaptor protein X11a interacts with the copper chaperone for SOD1 and regulates SOD1 activity. J. Biol. Chem. 276 (2001) 9303-9307
24. Ashley J., et al. Fasciclin II signals new synapse formation through amyloid precursor protein and the scaffolding protein dX11/Mint. J. Neurosci. 25 (2005) 5943-5955
25. Ho A., et al. A role for Mints in transmitter release: Mint 1 knockout mice exhibit impaired GABAergic synaptic transmission. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 1409-1414
26. Sabo S.L., et al. Regulation of β-amyloid secretion by FE65, an amyloid protein precursor-binding protein. J. Biol. Chem. 274 (1999) 7952-7957
27. Chang Y., et al. Generation of the β-amyloid peptide and the amyloid precursor protein C-terminal fragment γ are potentiated by FE65L1. J. Biol. Chem. 278 (2003) 51100-51107
28. Tanahashi H., and Tabira T. Characterization of an amyloid precursor protein-binding protein Fe65L2 and its novel isoforms lacking phosphotyrosine-interaction domains. Biochem. J. 367 (2002) 687-695
29. Ando K., et al. Phosphorylation-dependent regulation of the interaction of amyloid precursor protein with Fe65 affects the production of β-amyloid. J. Biol. Chem. 276 (2001) 40353-40361
30. Santiard-Baron D., et al. Expression of human FE65 in amyloid precursor protein transgenic mice is associated with a reduction in β-amyloid load. J. Neurochem. 93 (2005) 330-338
31. Borg J.P., et al. The X11B protein slows cellular amyloid precursor protein processing and reduces AB40 and AB42 secretion. J. Biol. Chem. 273 (1998) 14761-14766
32. Sastre M., et al. X11 interaction with β-amyloid precursor protein modulates its cellular stabilization and reduces amyloid β-protein secretion. J. Biol. Chem. 273 (1998) 22351-22357
33. McLoughlin D.M., et al. Mint2/X11-like co-localises with the Alzheimer's disease amyloid precursor protein and is associated with neuritic plaques in Alzheimer's disease. Eur. J. Neurosci. 11 (1999) 1988-1994
34. Tomita S., et al. PDZ domain-dependent suppression of NF-κB/p65-induced Aβ42 production by a neuron-specific X11-like protein. J. Biol. Chem. 275 (2000) 13056-13060
35. King G.D., et al. X11α impairs γ- but not β-cleavage of amyloid precursor protein. J. Neurochem. 88 (2004) 971-982
36. Lee D.-S., et al. Regulation of X11L-dependent APP metabolism by XB51, a novel X11L-binding protein. J. Biol. Chem. 275 (2000) 23134-23138
37. Mueller H.T., et al. Modulation of amyloid precursor metabolism by X11α/mint-1: a deletion analysis of protein-protein interaction domains. J. Biol. Chem. 275 (2000) 39302-39306
38. Xie Z., et al. RNAi-mediated silencing of X11alpha and X11beta attenuate Aβ levels via differential effects on APP processing. J. Biol. Chem. 280 (2005) 15413-15421
39. Lee J.H., et al. The neuronal adaptor protein X11alpha reduces Aβ levels in the brains of Alzheimer's APPswe Tg2576 transgenic mice. J. Biol. Chem. 278 (2003) 47025-47029
40. Lee J.H., et al. The neuronal adaptor protein X11beta reduces Aβ levels and amyloid plaque formation in the brains of transgenic mice. J. Biol. Chem. 279 (2004) 49099-49104
41. Yang L.B., et al. Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat. Med. 9 (2003) 3-4
42. Araki Y., et al. Novel cadherin-related membrane proteins, Alcadeins, enhance the X11-like protein-mediated stabilization of amyloid β-protein precursor metabolism. J. Biol. Chem. 278 (2003) 49448-49458
43. Lau K.-F., et al. X11alpha and X11beta interact with presenilin-1 via their PDZ domains. Mol. Cell. Neurosci. 16 (2000) 557-565
44. Khvotchev M., and Sudhof T.C. Proteolytic processing of APP by secretases does not require cell-surface transport. J. Biol. Chem. 279 (2004) 47101-47108
45. Amaratunga A., and Fine R.E. Generation of amyloidogenic C-terminal fragments during rapid axonal transport in vivo of β-amyloid precursor protein in the optic nerve. J. Biol. Chem. 270 (1995) 17268-17272
46. Buxbaum J.D., et al. Alzheimer amyloid protein precursor in the rat hippocampus: transport and processing through the perforant path. J. Neurosci. 18 (1998) 9629-9637
47. Koo E.H., et al. Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 1561-1565
48. Lazarov O., et al. Evidence that synaptically released beta-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice. J. Neurosci. 22 (2002) 9785-9793
49. Stokin G.B., et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307 (2005) 1282-1288
50. Okamoto M., et al. Ultrastructural localization of mint1 at synapses in mouse hippocampus. Eur. J. Neurosci. 12 (2000) 3067-3072
51. Vassar R. β-Secretase, APP and Aβ in Alzheimer's disease. Subcell. Biochem. 38 (2005) 79-103
52. Bush A.I. The metallobiology of Alzheimer's disease. Trends Neurosci. 26 (2003) 207-214
53. Multhaup G., et al. The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I). Science 271 (1996) 1406-1409
54. Cherny R.A., et al. Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30 (2001) 665-676
55. Sparks D.L., and Schreurs B.G. Trace amounts of copper in water induce β-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 11065-11069
56. Bayer T.A., et al. Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Aβ production in APP23 transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 14187-14192
57. Phinney A.L., et al. In vivo reduction of amyloid-β by a mutant copper transporter. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 14193-14198
58. Treiber C., et al. Clioquinol mediates copper uptake and counteracts Cu efflux activities of the amyloid precursor protein of Alzheimer's disease. J. Biol. Chem. 279 (2004) 51958-51964
59. Duquesne A.E., et al. Solution structure of the second PDZ domain of the neuronal adaptor X11α and its interaction with the C-terminal peptide of the human copper chaperone for superoxide dismutase. J. Biomol. NMR 32 (2005) 209-218
60. Wong P.C., et al. Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 2886-2891
61. Angeletti B., et al. BACE1 cytoplasmic domain interacts with the copper chaperone for superoxide dismutase-1 and binds copper. J. Biol. Chem. 280 (2005) 17930-17937
62. Vanderwerf S.M., et al. Copper specifically regulates intracellular phosphorylation of the Wilson's disease protein, a human copper-transporting ATPase. J. Biol. Chem. 276 (2001) 36289-36294
63. Heredia J., et al. Phosphorylation and Cu+ coordination-dependent DNA binding of the transcription factor Mac1p in the regulation of copper transport. J. Biol. Chem. 276 (2001) 8793-8797
64. Taylor D.R., et al. Assigning functions to distinct regions of the N-terminus of the prion protein that are involved in its copper-stimulated, clathrin-dependent endocytosis. J. Cell Sci. 118 (2005) 5141-5153
65. Ehehalt R., et al. Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J. Cell Biol. 160 (2003) 113-123
66. Abad-Rodriguez J., et al. Neuronal membrane cholesterol loss enhances amyloid peptide generation. J. Cell Biol. 167 (2004) 953-960
67. Riddell D.R., et al. Compartmentalization of β-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts. Curr. Biol. 11 (2001) 1288-1293
68. Benjannet S., et al. Post-translational processing of β-secretase (β-amyloid-converting enzyme) and its ectodomain shedding - the pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-β production. J. Biol. Chem. 276 (2001) 10879-10887
69. Walter J., et al. Phosphorylation regulates intracellular trafficking of β-secretase. J. Biol. Chem. 276 (2001) 14634-14641
70. Iadecola C., et al. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat. Neurosci. 2 (1999) 157-161